Navitas Life Sciences offer service "Clinical Services"

Navitas Life Sciences draws on experience partnering with over 100 innovator and generic life sciences companies to run a wide range of studies, including Phases 2-4, non-interventional studies, biosimilars, and BA/BE trials, having helped bring several life-saving drugs to market across multiple therapeutic areas with particular depth in oncology, alongside expertise in stem cell therapies and diagnostic imaging/contrast agents. A global team combines subject-matter and regulatory strategy expertise with audit-ready infrastructure and technology platforms built to maintain compliance while improving efficiency and reducing cost.